Evidence map›Paper›PMID 33358178›Full record

ReviewAdvances in biological regulation2021

Reconsidering phosphorylation in the control of inducible CARD11 scaffold activity during antigen receptor signaling.

Joel L Pomerantz

Open access · greenAbstract readReview
In one paragraph

Review in Advances in biological regulation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Joel L PomerantzDepartment of Biological Chemistry, Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Miller Research Building, Room 623, 733 N Broadway, Baltimore, MD, 21205, USA. Electronic address: joel.pomerantz@jhmi.edu.
Johns Hopkins University · US

Funding

Mechanisms of Control of Lymphocyte Activation and Proliferation by a Critical Signaling IntegratorR01AI148143 · NIAID · JOHNS HOPKINS UNIVERSITY · PI POMERANTZ, JOEL L · 2020 to 2024
$2.3M
Exploratory Studies of SPPL3R21AI143053 · NIAID · JOHNS HOPKINS UNIVERSITY · PI POMERANTZ, JOEL L · 2019 to 2020
$450k
NIAID NIH HHS R01 AI148143NIAID NIH HHS R21 AI143053
6 · The paper itself

Abstract

Protein phosphorylation is a commonly used regulatory step that controls signal transduction pathways in a wide array of biological contexts. The finding that a residue is phosphorylated, coupled with the observation that mutation of that residue impacts signaling, often forms the basis for concluding that the phosphorylation of that residue is a key signaling step. However, in certain cases, the situation is more complicated and warrants further study to obtain a clear mechanistic understanding of whether and how the kinase-mediated modification in question is important. CARD11 is a multi-domain signaling scaffold that functions as a hub in lymphocytes to transmit the engagement of antigen receptors into the activation of NF-κB, JNK and mTOR. The phosphorylation of the CARD11 autoinhibitory Inhibitory Domain in response to antigen receptor triggering has been proposed to control the signal-induced conversion of CARD11 from an inactive to an active scaffold in a step required for lymphocyte activation. In this review, I discuss recent data that suggests that this model should be reconsidered for certain phosphorylation events in CARD11 and propose possible experimental avenues for resolution of raised issues.

Indexed as

AnimalsCARD Signaling Adaptor ProteinsGuanylate CyclaseHumansLymphocyte ActivationNF-kappa BPhosphorylationReceptors, AntigenSignal TransductionCARD11 protein, humanCARD Signaling Adaptor ProteinsGuanylate CyclaseNF-kappa BReceptors, Antigen

Identifiers

PMID33358178
PMCPMC7920944
OpenAlexW3117160825

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.